bioRxiv Science⌕ Search

Biology subjects

Green, S. M.

Publications and source records attributed to Green, S. M..

3 recordsLinked to original sources

Borrelia burgdorferi bb0164 encodes a Na+/Ca2+ antiporter homolog with a novel role in Mn2+ homeostasis and infectivity

Borrelia burgdorferi, the Lyme disease causative agent, relies on trace metals for motility, growth, and virulence in the absence of metal transport homologues encoded in the genome. Previous studies characterized borrelial metal transporter (bmtA) as a manganese (Mn) transporter and speculated that it is the sole Mn transporter. An oxidative stress transposon library screen identified bb0164, annotated as a calcium/sodium antiporter, as having a putative metal binding domain. The transposon mutant lost the ability to internalize Mn suggesting B. burgdorferi is using a non-canonical protein for metal transport. In this study, a bb0164 deletion and complement were generated in B. burgdorferi 5A4-NP1 to evaluate for trace metal transport, virulence regulation, resistance to oxidative stress, and infectivity. Our data demonstrated that the loss of bb0164 resulted in a significant reduction in internalized Mn, increased sensitivity to oxidative stress, dysregulation of the BosR-RpoS virulence pathway, and a loss of infectivity in mice. The loss of bb0164 resulted in elevated rpoS, ospC, and dbpA expression and production, while bosR was not altered transcriptionally or post-transcriptionally. B. burgdorferi grown in chelated complete BSK-II media showed a similar sensitivity to oxidative stress and virulence dysregulation as the bb0164 mutant. These phenotypes were rescued by exogenous Mn and Zn without influencing the expression levels of bb0164 or bmtA. AlphaFold models of BB0164 were structurally divergent from the canonical bacterial Mn transporter, Bacillus subtilis MntH and B. burgdorferi BmtA, but shared high similarity with a calcium/cation antiporter superfamily member. Together, this study characterized BB0164 as a second non-canonical Mn transporter in B. burgdorferi that is essential for mammalian pathogenesis and likely supports metal homeostasis along with bmtA. More broadly, B. burgdorferi uses unique and uncharacterized mechanisms for metal homeostasis that supports physiology and pathogenesis of the spirochete during mammalian infection. Author SummaryLyme disease, caused by Borrelia burgdorferi, is the most common vector-borne illness in the United States and can result in a chronic inflammatory disease. B. burgdorferi acquires most of the necessary nutrients, including trace metals, from the host due to its limited metabolic capacity. B. burgdorferi has evolved a manganese-centric metabolism in place of the iron primarily used by other bacteria. Little is understood about manganese homeostasis in B. burgdorferi with a single transporter, BmtA, characterized to date. Here, we describe a second manganese transporter, encoded by bb0164, that is essential for infection, protects against oxidative stress, and alters genetic regulation. We found that BB0164, an annotated ion antiporter, does not structurally align with conserved manganese transporters from other bacteria. Interestingly, our work suggests bb0164 and bmtA are not subject to transcriptional regulation dependent on temperature or metal availability, differing from other bacterial manganese transporters. These findings indicate B. burgdorferi is uniquely using an antiporter protein for metal transport to support metal homeostasis, which further demonstrates the importance of manganese in borrelial pathogenesis.

microbiology↗

Mechanisms by Which Small Molecule Inhibitors Arrest Sec14 Phosphatidylinositol Transfer Protein Activity

Phosphatidylinositol transfer proteins (PITPs) promote phosphoinositide signaling by enhancing phosphatidylinositol (PtdIns) 4-OH kinase activities in producing signaling pools of PtdIns-4-phosphate. As such, PITPs are key regulators of lipid signaling in eukaryotic cells. While the PITP phospholipid exchange cycle is the engine that stimulates PtdIns 4-OH kinase activity, the protein and lipid dynamics associated with this critical process are not understood. Herein, we use an integrative structural approach that takes advantage of small molecule inhibitors (SMIs) directed against the major yeast PITP (Sec14) to gain new insights into the mechanics of the Sec14 phospholipid exchange cycle from the perspective of protein, phospholipid and SMI dynamics. Moreover, as Sec14 has emerged as an attractive target for next-generation antifungal drugs, the structures of Sec14 bound to SMIs of four different chemotypes reported in this study provide critical information required for structure-based design of next-generation lead compounds that target Sec14 PITPs of virulent fungi.

biophysics↗

A ROLE FOR CORTICAL DOPAMINE IN THE PARADOXICAL CALMING EFFECTS OF PSYCHOSTIMULANTS

Attention deficit hyperactivity disorder (ADHD) affects young children and manifests symptoms such as hyperactivity, impulsivity and cognitive disabilities. Psychostimulants, which are the primary treatment for ADHD, target monoamine transporters and have a paradoxical calming effect, but their mechanism of action, is unclear. Studies using the dopamine (DA) transporter (DAT) knockout mice, which have elevated striatal DA levels and are considered an animal model of ADHD, have suggested that the paradoxical calming effect of psychostimulants might be through the actions on serotonin neurotransmission. On the other hand, newer non-stimulant class of drugs such as atomoxetine and Intuniv suggest that targeting the norepinephrine (NE) system in the PFC might explain this paradoxical calming effect. We sought to decipher the mechanism of this paradoxical effect of psychostimulants through an integrated approach using ex vivo monoamine efflux experiments, monoamine transporter knockout mice, drug infusions and behavior. Our ex vivo efflux experiments reveal that NE transporter (NET) blocker desipramine elevates both norepinephrine and dopamine but not serotonin levels, in PFC tissue slices from wild-type and DAT-KO but not NET KO mice. However, serotonin (5-HT) transporter (SERT) inhibitor fluoxetine elevates only serotonin in all three genotypes. Systemic administration of both desipramine and fluoxetine but local PFC infusion of only desipramine and not fluoxetine inhibits hyperactivity in the DAT-KO mice. In contrast, pharmacological norepinephrine depletion but dopamine elevation using Nepicastat also inhibits hyperactivity in DATKO mice. Together, these data suggest that elevation of PFC dopamine and not norepinephrine or serotonin as a convergent mechanism for the paradoxical psychostimulant effects observe in ADHD therapy.

neuroscience↗